Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis

Apoptosis

Volumn 15, Issue 8, 2010, Pages 904-914

  Lee, Tzung Yan ^a   Lee, Ko Chen ^a,b   Chang, Hen Hong ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Andrographolide; Apoptosis; Cannabinoid receptor; Cholestasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ANDROGRAPHOLIDE; ASPARTATE AMINOTRANSFERASE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CYTOCHROME C; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN P30; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CANNABINOID 2 RECEPTOR; CNR2 PROTEIN, RAT; DITERPENE; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOME; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FIBROGENESIS; LIPID LIVER LEVEL; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SENESCENCE; SMOOTH MUSCLE; SPRAGUE DAWLEY RAT; ANIMAL; BILE DUCT; DRUG EFFECTS; FIBROSIS; LIGATION; LIVER; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SURGERY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BILE DUCTS; DITERPENES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROSIS; GLUTATHIONE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIGATION; LIVER; MALE; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; MURINAE; RATTUS;

EID: 77956905942     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0502-z     Document Type: Article

References (44)

1. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ (2002) Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123:1323-1330
2. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9:347-351
3. Schiff ER, Pockros P, Schiffman ML, McHutchinson J, Gish R, Afdhal NH, Makhviladze M, Oltersdorf T, Shapiro DA (2004) Oral IDN-6556, an anti apoptotic caspase inhibitor lowers ami-notransferases in HCV patients. J Hepatol 40:24
4. Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ (2004) The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 308:1191-1196
5. Xiao ZL, Chen Q, Biancani P, Behar J (2001) Abnormalities of gallbladder muscle associated with acute inflammation in guinea pigs. Am J Physiol Gastrointest Liver Physiol 281:G490-G497
6. Hasanein P, Shahidi S, Komaki A, Mirazi N (2008) Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis. Eur J Pharmacol 591:132-135
7. Gabbay E, Avraham Y, Ilan Y, Israeli E, Berry EM (2005) Endocannabinoids and liver disease. Liver Int 25:921-926
8. Sánchez C, de Ceballos ML, Gomez del Pulgar T, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Ramón y Cajal S, Guzmán M (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61:5784-5789
9. McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M (2002) Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100:627-634
10. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637-641
11. Derkinderen P, Ledent C, Parmentier M, Girault JA (2001) Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J Neurochem 77:957-960
12. Rueda D, Galve-Roperh I, Haro A, Guzman M (2000) The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 58:814-820
13. Anderson NL, Esquer-Blasco R, Richardson F, Foxworthy P, Eacho P (1996) The effects of peroxisome proliferators on protein abundances in mouse liver. Toxicol Appl Pharmacol 137:75-89
14. Fountoulakis M, de Vera MC, Crameri F, Boess F, Gasser R, Albertini S, Suter L (2002) Modulation of gene and protein expression by carbon tetrachloride in the rat liver. Toxicol Appl Pharmacol 183:71-80
15. Lee TY, Chang HH, Kuo JJ, Shen JJ (2009) Changes of hepatic proteome in bile duct ligated rats with hepatic fibrosis following treatment with Yin-Chen-Hao-Tang. Int J Mol Med 23:477-484
16. Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajago-palan R (2003) Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol 3:147-158
17. Gabrielian ES, Shukarian AK, Goukasova GI, Chandanian GL, Panossian AG, Wikman G, Wagner H (2002) A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine 9:589-597
18. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, Standish LJ (2000) A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 14:333-338
19. Shen YC, Chen CF, Chiou WF (2002) Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 135:399-406
20. Singha PK, Roy S, Dey S (2007) Protective activity of androg-rapholide and arabinogalactan proteins from Andrographis pan-iculata Nees, against ethanol-induced toxicity in mice. J Ethnopharmacol 111:13-21
21. Lee TY, Chang HH, Chen JH, Hsueh ML, Kuo JJ (2007) Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. J Ethnopharmacol 109:318-324
22. Lee TY, Chen FY, Chang HH, Lin HC (2009) The effect of capillarisin on glycochenodeoxycholic acid-induced apoptosis and heme oxygenase-1 in rat primary hepatocytes. Mol Cell Biochem 325:53-59
23. Lee TY, Mai LM, Wang GJ, Chiu JH, Lin YL, Lin HC (2003) Protective mechanism of salvia miltiorrhiza on carbon tetra-chloride-induced acute hepatotoxicity in rats. J Pharmacol Sci 91:202-210
24. Lee TY, Chang HH, Wu MY, Lin HC (2007) Yin-Chen-Hao-Tang ameliorates obstruction-induced hepatic apoptosis in rats. J Pharm Pharmacol 59:583-590
25. Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM Jr (1995) Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 109:1249-1256
26. Cantürk NZ, Canturk Z, Utkan NZ, Yenisey C, Ozbilim G, Yil-dirir C, Yalman Y (1998) Cytoprotective effects of alpha tocopherol against liver injury induced by extrahepatic biliary obstruction. East Afr Med J 75:77-80
27. Li J, Huang W, Zhang H, Wang X, Zhou H (2007) Synthesis of andrographolide derivatives and their TNF-alpha and IL-6 expression inhibitory activities. Bioorg Med Chem Lett 17:6891-6894 (Pubitemid 350061293)
28. Abu-Ghefreh AA, Canatan H, Ezeamuzie CI (2009) In vitro and in vivo anti-inflammatory effects of andrographolide. Int Immu-nopharmacol 93:313-318
29. Peres W, Tuñón MJ, Collado PS, Herrmann S, Marroni N, González-Gallego J (2000) The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol 33:742-750
30. Ebrahimkhani MR, Sadeghipour H, Dehghani M, Kiani S, Pa-yabvash S, Riazi K (2005) Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis. Life Sci 76:2497-2512
31. Ip YT, Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10:205-219
32. Chen YR, Meyer CF, Tan TH (1996) Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem 271:631-634
33. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185
34. Roulston A, Reinhard C, Amiri P, Williams LT (1998) Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 273:10232-10239
35. Ozaki I, Tani E, Ikemoto H, Kitagawa H, Fujikawa H (1999) Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3 like proteases but is dispensable for cell death. J Biol Chem 274:5310-5317
36. Chen JH, Hsiao G, Lee AR, Wu CC, Yen MH (2004) Androg-rapholide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. Biochem Pharmacol 67:1337-1345
37. Pacher P, Gao B (2008) Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases. Am J Physiol Gastrointest Liver Physiol 294:G850-G854
38. Teixeira-Clerc F, Julien B, Grenard P, Tran VN, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S (2006) CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 12:671-676
39. Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM (2009) Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 51:528-534
40. Avraham Y, Zolotarev O, Grigoriadis NC, Poutahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y, Mechoulam R, Berry EM (2008) Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am J Gastroenterol 103:3047-3056
41. Rajesh M, Pan H, Mukhopadhyay P, Bátkai S, Osei-Hyiaman D, Haskó G, Liaudet L, Gao B, Pacher P (2007) Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/ reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol 82:1382-1389
42. Mallat A, Teixeira-Clerc F, Deveaux V, Lotersztajn S (2007) Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases. Exp Opin Ther Targets 11:403-409
43. Nollen EA, Morimoto RI (2002) Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci 115:2809-2816
44. Rao RV, Peel A, Logvinova A, del Rio G, Hermel E, Yokota T, Goldsmith PC, Ellerby LM, Ellerby HM, Bredesen DE (2002) Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 514:122-128